Classification of distinct lung diseases using novel enhanced long short-term memory based optimization methodology.

Publication date: Jun 24, 2026

Lung disease classification using chest X-ray (CXR) images has become essential for early diagnosis and improved clinical decision-making. However, challenges such as low image quality, feature similarity among diseases, and classification instability reduce diagnostic reliability. To address these issues, this study proposes a novel ELSTM-AZOA framework for multiclass lung disease classification using the NIH CXR dataset. Initially, the collected CXR images are preprocessed using the balance contrast enhancement technique to improve image quality. U-Net +  + is then employed for accurate lung region segmentation, followed by feature extraction using statistical and gray level co-occurrence matrix features. The extracted features are classified using an enhanced long short-term memory (ELSTM) network, while the American zebra optimization algorithm (AZOA) optimizes the model parameters to maximize classification accuracy. The proposed framework classifies six categories: healthy lung, tuberculosis, pneumonia, lung cancer, COPD, and COVID-19. Experimental results demonstrate that the proposed ELSTM-AZOA model achieves superior performance compared with existing methods, obtaining 6. 36% higher accuracy and 6. 43% higher precision. The findings confirm that the proposed framework provides robust, reliable, and promising computer-aided lung disease classification.

Open Access PDF

Concepts Keywords
Cancer GLCM features
Matrix Lung disease classification
Pneumonia NIH CXR dataset
Reliable Statistical features
Zebra U-Net +  + 

Semantics

Type Source Name
disease MESH lung diseases
disease MESH image
drug DRUGBANK Isoxaflutole
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH pneumonia
disease MESH lung cancer
disease MESH COPD
disease MESH COVID-19
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Coenzyme M
drug DRUGBANK MCC
drug DRUGBANK Flunarizine
disease MESH respiratory diseases
disease MESH lung sound
disease MESH infection
disease MESH GAN
disease MESH SVD
disease MESH glaucoma
disease MESH tumor
disease MESH aids
drug DRUGBANK Icodextrin
disease MESH spotting
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Water
pathway REACTOME Translation
drug DRUGBANK Resiniferatoxin
disease MESH Confusion
drug DRUGBANK Saquinavir
disease MESH CAM
drug DRUGBANK Guanosine
disease MESH pneumothorax
drug DRUGBANK Carboxyamidotriazole
disease MESH Face
disease MESH Poisoning
disease MESH Interstitial Lung Diseases
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH STEMI
drug DRUGBANK Lithium cation
drug DRUGBANK Medical air
disease MESH macular edema
disease MESH Brain Tumor
drug DRUGBANK Sulpiride

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *